TrialBMC cancer2022

Adjuvant therapy with gemcitabine and stereotactic body radiation therapy versus gemcitabine alone for resected stage II pancreatic cancer: a prospective, randomized, open-label, single center trial.

Tao Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.